Mission Pharmacal

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Jun 28, 2019FDAThiola Ec — THIOLA EC

Apr 1, 2017TrialPhase II Proof of Concept Study in Uncomplicated UTI

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

1 patent group across drugs · Source: FDA Orange Book

DrugExpires

Thiola EcNov 14, 2038

Regulatory

Regulatory Timeline

19821 event

FDADec 28

Calcibind — CALCIBIND

Application NDA018757 (NDA)

19831 event

FDAMay 31

Lithostat — LITHOSTAT

Application NDA018749 (NDA)

19851 event

FDAAug 30

Potassium Citrate — UROCIT-K

Application NDA019071 (NDA)

19882 events

FDAOct 13

Potassium Citrate — POTASSIUM CITRATE

Application NDA019647 (NDA)

FDAAug 11

Thiola Ec — THIOLA

Application NDA019569 (NDA)

20041 event

FDAMay 17

Tindamax — TINDAMAX

Application NDA021618 (NDA)

20191 event

FDAJun 28

Thiola Ec — THIOLA EC

Application NDA211843 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)